219
Participants
Start Date
January 31, 2001
Study Completion Date
June 30, 2002
IV azithromycin
500 mg once daily
ceftriaxone
1 gram once daily for 2 to 5 days
oral azithromycin
2 x 250 mg once daily
IV levofloxacin
500 mg once daily
oral levofloxacin
500 mg once daily
Pfizer Investigational Site, New York
Pfizer Investigational Site, Mineola
Pfizer Investigational Site, Maroussi. Attikis
Pfizer Investigational Site, Sellersville
Pfizer Investigational Site, Philadelphia
Pfizer Investigational Site, Winston-Salem
Pfizer Investigational Site, Fort Gordon
Pfizer Investigational Site, Columbus
Pfizer Investigational Site, Columbus
Pfizer Investigational Site, Sarasota
Pfizer Investigational Site, Birmingham
Pfizer Investigational Site, Louisville
Pfizer Investigational Site, Columbus
Pfizer Investigational Site, Cleveland
Pfizer Investigational Site, Detroit
Pfizer Investigational Site, St Louis
Pfizer Investigational Site, Kirkwood
Pfizer Investigational Site, Shawnee Mission
Pfizer Investigational Site, San Antonio
Pfizer Investigational Site, Long Beach
Pfizer Investigational Site, Sylmar
Pfizer Investigational Site, Royal Oak
Pfizer Investigational Site, Albuquerque
Pfizer Investigational Site, Winnipeg
Pfizer Investigational Site, Halifax
Pfizer Investigational Site, Hamilton
Pfizer Investigational Site, London
Pfizer Investigational Site, Ottawa
Pfizer Investigational Site, Montreal
Pfizer Investigational Site, Ste-foy
Pfizer Investigational Site, Regina
Pfizer Investigational Site, Saskatoon
Pfizer Investigational Site, Rotenburg (Wümme)
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Lüdenscheid
Pfizer Investigational Site, Barcelona
Pfizer Investigational Site, Tarrasa
Lead Sponsor
Pfizer
INDUSTRY